The antibiotic vancomycin shares many similarities with ristocetin, an agent noted for its effects on platelets and plasma fibrinogen. Vancomycin did not aggregate platelets as ristocetin, but platelets were incorporated into precipitates induced by vancomycin. Fibrinogen and factor VIII were precipitated from plasma at low concentrations of vancomycin. The precipitated fibrinogen remained clottable. Hepatitis B surface antigen was selectively precipitated from serum and could be recovered from the precipitate. Rabbits receiving bolus intravenous injections of high doses of vancomycin developed hypofibrinogenemia and thrombocytopenia within minutes and often went on to die. Studies with 125I-vancomycin revealed little stable binding of the antibiotic to platelets or fibrinogen. A relationship is suggested between the potent protein precipitating effects and phlebitis at the infusion site commonly associated with vancomycin therapy.
* Current address, Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut.
References
1
Alter H. J,
Holland P. V,
and
Purcell R. H.
1971; Counterelectrophoresis for detection of hepatitis associated antigen: methodology and comparison with gel diffusion and complement fixation. Journal of Laboratory and Clinical Medicine 77: 1000.
6
Gralnick H. R,
Givelber H. M,
Shainoff J. R.
et al.
1971; Fibrinogen Be-thesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. Journal of Clinical Investigation 50: 1819.
7
Howard M. A,
and
Firkin B. G.
1971; Ristocetin - a new tool in the investigation of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 26: 362.
9
Kirby W. M. M,
and
Divelbiss C. L.
1957. Vancomycin: clinical and laboratory studies. In: Antibiotics Annual 1956-57. Medical Encyclopedia, Inc.; New York: 107.
10
Ling C. M,
and
Oresby L. R.
1972; Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125I-antibody. Journal of Immunology 109: 834.
11
MacLowry J. D,
Jaqua M. J,
and
Selepak S. T.
1970; Detailed methodology and implementation of a semi-automated serial dilution microtechnique for antimicrobial susceptibility testing. Applied Microbiology 20: 46.
12
Mancini G,
Carbonara A. O,
and
Heremans J. F.
1965; Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235.
13
McCormick M. H,
Stark W. M,
and
Pittenger G. E.
et al.
1956. Vancomycin, a new antibiotic. I. Chemical and biologic properties. In: Antibiotics Annual 1955-1956. Medical Encyclopedia, Inc.; New York: 606.
14
Nieto M,
and
Perkins H. R.
1971; Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine. Biochemical Journal 123: 773.
15
Nieto M,
and
Perkins H. R.
1971; The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors. Biochemical Journal 124: 845.
16
Romansky M. J,
Limson B. M,
and
Hawkins J. E.
1957. Ristocetin: a new antibiotic-laboratory and clinical studies. Preliminary report. In: Antibiotics Annual 1956-57. Medical Encyclopedia, Inc.; New York: 706.
17
Simone J. V,
Vanderherden J,
and
Abildgaard C. F.
1967; A semi-automatic one-stage factor VIII assay with a commercially prepared standard. Journal of Laboratory and Clinical Medicine 59: 706.
18
Tangen O,
and
Berman H. J.
1972. Gel filtration of blood platelets: a methodological report. In:
Manucci P. M,
and
Gorini S.
(ed.)
Platelet Function and Thrombosis. Plenum Press; New York.: 235.
19
Warsbren B. A,
Kleinerman L,
and
Skemp J.
et al.
1960. The comparative toxicity and clinical effectiveness of vancomycin, ristocetin and kanamycin. In: Antibiotics Annual 1959-60. Medical Encyclopedia, Inc.; 497.
